QQ客服 官方微博 反馈留言

浏览/检索结果: 共7条，第1-7条 帮助 限定条件 发表日期：2018     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Discovery of Potent Irreversible Pan-Fibroblast Growth Factor Receptor (FGFR) Inhibitors 期刊论文 JOURNAL OF MEDICINAL CHEMISTRY, 2018, 卷号: 61, 期号: 20, 页码: 9085-9104 作者:  Wang, Yuming;  Li, Lijun;  Fan, Jun;  Dai, Yang;  Jiang, Alan 收藏  |  浏览/下载：30/0  |  提交时间：2019/01/08 Design, synthesis and biological evaluation of a series of novel 2-benzamide-4-(6-oxy-N-methyl-l-naphthamide)-pyridine derivatives as potent fibroblast growth factor receptor (FGFR) inhibitors 期刊论文 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 卷号: 154, 页码: 9-28 作者:  Wei, Manman;  Peng, Xia;  Xing, Li;  Dai, Yang;  Huang, Ruimin 收藏  |  浏览/下载：63/0  |  提交时间：2019/01/08 FGFR  VEGFR  Synergistic effect  Tumor growth inhibition  Lucitanib   Discovery of 4-((N-(2-(dimethylamino)ethyl)acrylamido)methyl)-N-(4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)benzamide (CHMFL-PDGFR-159) as a highly selective type II PDGFR alpha kinase inhibitor for PDGFR alpha driving chronic eosinophilic leukemia 期刊论文 EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 卷号: 150, 期号: 无, 页码: 366-384 作者:  Wang, Qiang;  Liu, Feiyang;  Qi, Shuang;  Qi, Ziping;  Yan, Xiao-E. 收藏  |  浏览/下载：62/0  |  提交时间：2019/06/10 PDGFR kinase  Type II inhibitor  Kinase inhibitor  CEL   PBA2 exhibits potent anti-tumor activity via suppression of VEGFR2 mediated-cell proliferation and angiogenesis 期刊论文 BIOCHEMICAL PHARMACOLOGY, 2018, 卷号: 150, 页码: 131-140 作者:  Fang, Xiaona;  Xie, Hua;  Luo, Min;  Chen, Zhen;  Wang, Fang 收藏  |  浏览/下载：34/0  |  提交时间：2019/01/08 Angiogenesis  And-tumor activity  Multi-tyrosine kinases inhibitor  PBA2  VEGFR2   Preclinical characterization of anlotinib, a highly potent and selective vascular endothelial growth factor receptor-2 inhibitor 期刊论文 CANCER SCIENCE, 2018, 卷号: 109, 期号: 4, 页码: 1207-1219 作者:  Xie, Chengying;  Wan, Xiaozhe;  Quan, Haitian;  Zheng, Mingyue;  Fu, Li 收藏  |  浏览/下载：43/0  |  提交时间：2019/01/08 angiogenesis  anlotinib  tyrosine kinase inhibitor  VEGF  VEGFR2   Chlorogenic acid attenuates diabetic retinopathy by reducing VEGF expression and inhibiting VEGF-mediated retinal neoangiogenesis 期刊论文 Vascular pharmacology, 2018, 卷号: 101, 页码: 29-37 作者:  Mei, Xiyu;  Zhou, Lingyu;  Zhang, Tianyu;  Lu, Bin;  Sheng, Yuchen 收藏  |  浏览/下载：52/0  |  提交时间：2019/01/08 Dioscin suppresses the viability of ovarian cancer cells by regulating the VEGFR2 and PI3K/AKT/MAPK signaling pathways 期刊论文 ONCOLOGY LETTERS, 2018, 卷号: 15, 期号: 6, 页码: 9537-9542 作者:  Guo, Xianqing;  Ding, Xiao 收藏  |  浏览/下载：10/0  |  提交时间：2019/12/11 dioscin  ovarian cancer cells  vascular endothelial growth factor  receptor 2  phosphoinositide 3-kinase/protein kinase B  mitogen-activated protein kinase